FINAL RESULTS FROM THE NUPROTECT STUDY OF NUWIQ (R) (SIM OCT OCOG ALFA) TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A

Liesner R. J.; Jansen M.; Knaub S.

首页> 外文期刊>Archives of disease in childhood >FINAL RESULTS FROM THE NUPROTECT STUDY OF NUWIQ (R) (SIM OCT OCOG ALFA) TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A

【24h】

FINAL RESULTS FROM THE NUPROTECT STUDY OF NUWIQ (R) (SIM OCT OCOG ALFA) TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A

机译：在以前未经治疗的严重血友病患者中，NuWIQ（R）（SIMOT OCOG OCO ALFA）治疗的NuProtect研究的最终结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Archives of disease in childhood》 |2019年第1期|共1页
作者
Liesner R. J.; Jansen M.; Knaub S.;
展开▼
作者单位

Great Ormond Hosp Children NHS Trust Haemophilia Ctr London England;

Octapharma Pharmazeut Prod Ges MbH Vienna Austria;

Octapharma AG Lachen Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. FINAL RESULTS FROM THE NUPROTECT STUDY OF NUWIQ (R) (SIM OCT OCOG ALFA) TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A [J] . Liesner R. J., Jansen M., Knaub S. Archives of disease in childhood . 2019,第Suppla1期

机译：在以前未经治疗的严重血友病患者中，NuWIQ（R）（SIMOT OCOG OCO ALFA）治疗的NuProtect研究的最终结果
2. COMBINATION OF EMICIZUMAB WITH SIM OCT OCOG ALFA FOR PROPHYLAXIS IN PREVIOUSLY UNTREATED/MINIMALLY TREATED HEMOPHILIA A PATIENTS, AND FOR MANAGING INHIBITOR PATIENTS [J] . Sidonio R., Meeks S. L., Shapiro A., Archives of disease in childhood . 2019,第Suppla1期

机译：Emicizumab与SIM OCTOOG ALFA在先前未经治疗/最低治疗的血友病患者中的预防，并用于管理抑制剂患者
3. Immunogenicity, efficacy and safety of Nuwiq ? ? (human‐cl rh FVIII FVIII ) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study [J] . Liesner R. J., Abashidze M., Aleinikova O., Haemophilia: the official journal of the World Federation of Hemophilia . 2018,第2期

机译：nuwiq的免疫原性，疗效和安全性？还（人ClR RH FVIII FVIII）在以前未经处理的患有严重的血友病患者A-中期结果来自NuProtect研究
4. Dynamic of Thrombin Generation in Patients with Severe Hemophilia A [C] . F. Wenzel, H. H. Brackmann, J. Oldenburg Hemophilia Symposium . 2008

机译：严重血友病患者凝血酶生成的动态
5. Satisfaction, Adherence, and Recombinant Factor VIII Choice of Patients with Moderate to Severe Hemophilia A [D] . Strickland, Kimberly. 2020

机译：满意度，依从性和重组因素VIII患者中度至重度血友病的患者
6. Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program [O] . Toshko Lissitchkov, Anna Klukowska, John Pasi, 2019

机译：辛法考克阿尔法（Nuwiq®）在严重血友病A中的疗效和安全性：GENA计划的临床试验数据回顾
7. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study [O] . Ri J. Liesner, Aby Abraham, Carmen Altisent, 2021

机译：Simoctocog Alfa（Nuwiq）在以前未经治疗的严重血耳患者中A：NuProtect研究的最终结果

FINAL RESULTS FROM THE NUPROTECT STUDY OF NUWIQ (R) (SIM OCT OCOG ALFA) TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A

著录项

相似文献

相关主题

期刊订阅